Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Corning today announced an agreement to purchase the majority of Becton Dickinson's Discovery Labware unit for $730 million in cash.

BD's Advanced Bioprocessing platform is not included in the deal, BD said.

The deal, which is expected to be completed later this year, will increase Corning's global market access and enhance its product portfolio in drug discovery tools, bioprocess solutions, and laboratory research instruments, Corning said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.